Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/17/26 18:53 | 2/16/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Snyder Mark Howard | CA | O | SVP,GC | 2 | M.d | 0 | 0.00 | 0 | 24 | 140 | 42 | D | ||||||||||||||
2/17/26 18:52 | 2/16/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | 1 | M.d | 0 | 0.00 | 0 | 24 | 259 | 33 | D | ||||||||||||||
2/17/26 18:51 | 2/16/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 5 | M.dm | 5,733 | 25.80 | 0 | 222 | 42 | 750 | D | ||||||||||||||
1/6/26 18:55 | 1/5/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Connaughton Bernadette | CA | D | 2 | S | -200 | 70.65 | 0 | -3 | 42 | D | ||||||||||||||||
12/19/25 17:39 | 11/1/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Caudill Cortney | CA | O | SVP,COO | 2 | M.d | 278 | 20.45 | 0 | 14 | 13 | D | |||||||||||||||
12/19/25 17:39 | 11/1/25 | HALO | Health | BioPrd | Biological Products, (No Diag | Caudill Cortney | CA | O | SVP,COO | 2 | S.d | -278 | 20.45 | 0 | -14 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |